ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,299,000 | -10.6% | 375,070 | -0.8% | 0.15% | -19.1% |
| Q4 2020 | $17,116,000 | +28.8% | 378,167 | +0.7% | 0.18% | +10.9% |
| Q3 2020 | $13,288,000 | -1.8% | 375,498 | +4.7% | 0.16% | -9.8% |
| Q2 2020 | $13,526,000 | +43.4% | 358,482 | +9.9% | 0.18% | +22.0% |
| Q1 2020 | $9,434,000 | -17.2% | 326,319 | +48.4% | 0.15% | +12.8% |
| Q4 2019 | $11,398,000 | -44.1% | 219,818 | -40.8% | 0.13% | -48.0% |
| Q3 2019 | $20,397,000 | +35.3% | 371,596 | +0.1% | 0.26% | +30.6% |
| Q2 2019 | $15,077,000 | +89.2% | 371,190 | +40.9% | 0.20% | +81.5% |
| Q1 2019 | $7,969,000 | -5.0% | 263,515 | +5.6% | 0.11% | -18.8% |
| Q4 2018 | $8,386,000 | -8.0% | 249,537 | +15.5% | 0.13% | +5.6% |
| Q3 2018 | $9,116,000 | +24.9% | 216,131 | -5.2% | 0.13% | +17.8% |
| Q2 2018 | $7,298,000 | -37.2% | 228,073 | -2.4% | 0.11% | -39.2% |
| Q1 2018 | $11,621,000 | -13.8% | 233,735 | -6.6% | 0.18% | -11.1% |
| Q4 2017 | $13,485,000 | -9.6% | 250,148 | -2.8% | 0.20% | -14.7% |
| Q3 2017 | $14,922,000 | +15.4% | 257,278 | -1.8% | 0.23% | +11.5% |
| Q2 2017 | $12,926,000 | -12.8% | 261,992 | -23.2% | 0.21% | -10.0% |
| Q1 2017 | $14,824,000 | -60.7% | 341,249 | -55.7% | 0.23% | -22.7% |
| Q4 2016 | $37,702,000 | +96.7% | 770,044 | +92.2% | 0.30% | -5.4% |
| Q3 2016 | $19,171,000 | -26.5% | 400,644 | -17.6% | 0.32% | -29.1% |
| Q2 2016 | $26,095,000 | +18.2% | 486,394 | -1.5% | 0.45% | +16.1% |
| Q1 2016 | $22,082,000 | +15.8% | 493,780 | -1.2% | 0.38% | +8.5% |
| Q4 2015 | $19,062,000 | -12.9% | 499,537 | -27.3% | 0.35% | -3.3% |
| Q3 2015 | $21,885,000 | -2.9% | 687,536 | +0.8% | 0.37% | +6.4% |
| Q2 2015 | $22,533,000 | -21.8% | 682,200 | -2.5% | 0.34% | -19.6% |
| Q1 2015 | $28,801,000 | -1.0% | 699,562 | -2.0% | 0.43% | -1.2% |
| Q4 2014 | $29,086,000 | +99.2% | 713,947 | +79.3% | 0.43% | +92.4% |
| Q3 2014 | $14,599,000 | – | 398,214 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |